Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucose toxicity.

L Rossetti1, A Giaccari, R A DeFronzo

  • 1Department of Medicine, University of Texas Health, San Antonio 78284.

Diabetes Care
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

High blood sugar, or hyperglycemia, worsens diabetes by impairing insulin secretion and potentially causing insulin resistance. Managing glucose levels is crucial for both type I and type II diabetes patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence-based recommendations for the use of continuous glucose monitoring in type 2 diabetes: the Italian guidelines.

Acta diabetologica·2026
Same author

What can we learn from systematic segmental analysis of fetal heart by postmortem micro-CT: Is it time to change approach?

International journal of cardiology. Congenital heart disease·2024
Same author

The pasture system improves natural antioxidants and functional lipids while reducing lipid peroxidation in Ctenopharyngodon idella (grass carp) burgers during storage.

Food chemistry·2024
Same author

Retraction Note: Autoantibodies detection in patients affected by autoimmune retinopathies.

European review for medical and pharmacological sciences·2024
Same author

Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study.

Journal of endocrinological investigation·2024
Same author

Autoantibodies detection in patients affected by autoimmune retinopathies.

European review for medical and pharmacological sciences·2023
Same journal

Type 1 Diabetes Driven by Residual Recipient T Cells After Hematopoietic Cell Transplantation: A Case Report.

Diabetes care·2026
Same journal

Predicting the Path to Attrition: Multidomain Risk Assessment in Diabetic Foot Ulcer Offloading Randomized Controlled Trials.

Diabetes care·2026
Same journal

Habituation to Elevated Glucose Levels in Type 1 Diabetes: Function and Well-Being in Guideline-Based Versus Typical Glycemic Range.

Diabetes care·2026
Same journal

The Correlation Between Fear and Perceived Frequency of Hypoglycemia and Continuous Glucose Monitoring Metrics in Adults With Type 1 Diabetes Using Diabetes Technology: A One-Year Analysis.

Diabetes care·2026
Same journal

A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes.

Diabetes care·2026
Same journal

Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies.

Diabetes care·2026
See all related articles

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Diabetes Pathophysiology

Background:

  • Glucose toxicity is a recognized factor in diabetes development.
  • Chronic hyperglycemia contributes to insulin resistance and impaired insulin secretion in type II diabetes.
  • Evidence suggests hyperglycemia also impacts insulin secretion and resistance in type I diabetes.

Purpose of the Study:

  • To elucidate the mechanisms of hyperglycemia-induced insulin secretion defects.
  • To explore the role of glucose toxicity in insulin resistance across diabetes types.
  • To investigate potential differences in hyperglycemia effects between humans and animal models.

Main Methods:

  • Review of existing literature on glucose toxicity in animal models and human diabetes.

Related Experiment Videos

  • Analysis of evidence linking plasma glucose concentration to insulin secretion and resistance.
  • Examination of biochemical pathways, including phosphoinositide metabolism and glucose transport.
  • Comparison of hyperglycemia effects in type I and type II diabetes, and across species.

    • Main Results:

    • Hyperglycemia progressively impairs insulin secretion and may contribute to insulin resistance in type II diabetes.
    • Downregulation of the glucose-transport system is implicated in hyperglycemia-induced insulin resistance.
    • Humans may experience defects in glycogen synthesis due to hyperglycemia, potentially differing from rats.
    • Improved glycemic control ameliorates insulin resistance in poorly controlled type I diabetes.
    • Hyperglycemia is implicated in impaired insulin secretion during initial type I diabetes presentation, explaining the honeymoon period.

    Conclusions:

    • Glucose toxicity is a significant contributor to the pathophysiology of both type I and type II diabetes.
    • Understanding the mechanisms of glucose toxicity is vital for developing effective diabetes management strategies.
    • Tight glycemic control is essential for mitigating hyperglycemia-induced complications in diabetes.